GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kelyniam Global Inc (OTCPK:KLYG) » Definitions » Debt-to-EBITDA

Kelyniam Global (Kelyniam Global) Debt-to-EBITDA : -0.23 (As of Mar. 2008)


View and export this data going back to 2008. Start your Free Trial

What is Kelyniam Global Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Kelyniam Global's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2008 was $0.03 Mil. Kelyniam Global's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2008 was $0.02 Mil. Kelyniam Global's annualized EBITDA for the quarter that ended in Mar. 2008 was $-0.22 Mil. Kelyniam Global's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2008 was -0.23.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Kelyniam Global's Debt-to-EBITDA or its related term are showing as below:

KLYG's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.26
* Ranked among companies with meaningful Debt-to-EBITDA only.

Kelyniam Global Debt-to-EBITDA Historical Data

The historical data trend for Kelyniam Global's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kelyniam Global Debt-to-EBITDA Chart

Kelyniam Global Annual Data
Trend Dec06 Dec07
Debt-to-EBITDA
-1.00 -0.34

Kelyniam Global Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
Debt-to-EBITDA Get a 7-Day Free Trial 1.81 0.26 -3.00 -0.06 -0.23

Competitive Comparison of Kelyniam Global's Debt-to-EBITDA

For the Medical Devices subindustry, Kelyniam Global's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kelyniam Global's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kelyniam Global's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Kelyniam Global's Debt-to-EBITDA falls into.



Kelyniam Global Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Kelyniam Global's Debt-to-EBITDA for the fiscal year that ended in Dec. 2007 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.031 + 0.023) / -0.157
=-0.34

Kelyniam Global's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2008 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.028 + 0.021) / -0.216
=-0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2008) EBITDA data.


Kelyniam Global  (OTCPK:KLYG) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Kelyniam Global Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Kelyniam Global's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Kelyniam Global (Kelyniam Global) Business Description

Traded in Other Exchanges
N/A
Address
97 River Road, Suite A, Canton, CT, USA, 06019
Kelyniam Global Inc is a medical device manufacturing company that specializes in the production of custom skull implants utilizing computer-aided design and bio-compatible medical grade polymers.